resulting in the formation of NO [36] . Therefore, the protective role of Ngb against NO in vivo is controversial [32, 33, 37] . Although in vitro Ngb does not react with hydrogen peroxide (H 2 O 2 ) [25, 30] and the Ngb-NO 2 adduct reacts with H 2 O 2 facilitating the nitration of aromatic substrates [30] , the correlation between reactive oxygen species formation/decomposition and Ngb expression in vivo is debated [15, 38] . Moreover, Ngb has been reported to interact with several proteins (see [ 15] ). In particular, Ngb binding to the G ␣ protein inhibits GDP dissociation, thereby protecting cells from apoptosis [39, 40] . Recently, in silico simulations indicate Ngb capability to reduce cytochrome c released from mitochondria suggesting its protective role against programmed cell death [19, [41] [42] [43] .
Although Ngb properties are highly debated [12, 15, 19, 33, 44] , it is unlikely that Ngb has so many distinct roles [15] ; nevertheless, there is no doubt that Ngb is beneficial to neurons [15] . In vivo experiments, using transgenic rodents, have shown that increased levels of Ngb significantly protect both heart and brain tissues from hypoxic insult, whereas decreased Ngb levels lead to an exacerbation of tissue death [45] [46] [47] . In this way, Ngb could protect neurons from hypoxic insult by modulating the activation of the apoptotic cascade [19, 41] . A significant contribution to highlight the role played by Ngb in neuroprotection could derive from the identification of Ngb endogenous modulator(s) (e.g., hormones and neurotransmitters), but, as far as we know, no Ngb involvement in the hormone signal transduction pathways has been identified yet.
Female sex steroid hormones could represent good candidates as Ngb modulators. Indeed, in addition to their well-established role in reproductive organs, estrogens affect areas of the brain that are not primarily involved in reproduction [48] . Growing evidence documents profound effects of estrogens on learning, memory, and mood as well as neurodevelopmental and neurodegenerative processes [49, 50] . Although most studies have been conducted on females, there is mounting recognition that estrogens play important roles in the male brain, where they can be generated from circulating testosterone by local aromatase or synthesized de novo by neurons and glia [51] . Several sources of evidence confirm that estrogens serve as neurotrophic and neuroprotective agents. Notably, 17 ␤ -estradiol (E 2 ) attenuates the toxicity of the amyloid-␤ peptide and glutamate in a hippocampal cell line [52] . In addition, estrogen therapy in post-menopausal women is associated with decreased incidence and enhanced recovery from ischemic stroke [51] . The protective effects of estrogens have been widely reported in different types of neuronal cells against a variety of insults, including H 2 O 2 [53, 54] , serum deprivation [55] , oxygen-glucose deprivation [56] , and iron [57] . Due to myriad and often tissue-specific estrogen effects, the precise molecular events that mediate these protective actions are not fully understood. Here, we evaluate the possibility that Ngb could be part of 17 ␤ -estradiolinduced signals and effects in neuronal cells.
Materials and Methods
Reagents E 2 , testosterone (T), 5 ␣ -androstan-17 ␤ -ol-3-one (dihydrotestosterone, DHT), naringenin (Nar), insulin-like growth factor 1 (IGF-1), actinomycin D (Act), cycloheximide (Cxm), Pen-Strep solution, H 2 O 2 , RPMI-1640 media without phenol red, and charcoal-stripped fetal calf serum, the palmitoyl acyltransferase (PAT) inhibitor 2-bromohexadecanoid acid (2-Br-palmitate; 2-Br), the protease inhibitor cocktail, and the bovine serum albumin fraction V (BSA) were purchased from Sigma-Aldrich (St. Louis, Mo., USA).
Optimem, Hank's buffer salt solution (HBSS 1 ! ), Neurobasal medium, B27 serum-free supplement, and GlutaMAX-I were purchased from Gibco-BRL (Gaithersburg, Md., USA). The p38 inhibitor SB 203 580 (SB), the AKT inhibitor, and the IGF-1 receptor (IGF-1R) inhibitor picropodophyllin (PPP) were obtained from Calbiochem (San Diego, Calif., USA). The E 2 antagonist fulvestrant (ICI 182,780, ICI), the estrogen receptor (ER) ␣ -selective agonist 4,4 ,4 -(4-propyl- [ 1 H]-pyrazole-1,3,5-triyl)trisphenol (PPT), the ER ␤ -selective agonist 2,3-bis(4-hydroxyphenyl)propionitrile (DPN), and the ER ␤ -selective antagonist (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol (THC) were obtained from Tocris (Ballwin, Mo., USA). Bradford protein assay was obtained from Bio-Rad Laboratories (Hercules, Calif., USA). The human recombinant ER ␣ and ER ␤ were obtained by PanVera (Madison, Wisc., USA). The anti-phospho-ERK1/2, anti-AKT, anti-ER ␣ (MC20), anti-ER ␤ (H150), anti-caspase-3, antipoly(ADP-ribose)polymerase (PARP), and anti-ERK1/2 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, Calif., USA). The polyclonal anti-phospho-AKT, anti-phosphop38, and anti-p38 antibodies were purchased from New England Biolabs (Beverly, Mass., USA). The monoclonal anti-human Ngb (13C8) was purchased from Abcam (Cambridge, UK). The anti-␤ -tubulin was purchased from MP Biomedical (Solon, Ohio, USA). The chemiluminescence reagent for Western blot ECL was obtained from GE Healthcare (Little Chalfont, UK). All the other products were from Sigma-Aldrich. Analytical or reagent grade products were used without further purification.
Cells
The human SK-N-BE neuroblastoma cell line was routinely grown in air containing 5% CO 2 in modified, phenol red-free, RPMI-1640 medium containing 10% (v/v) charcoal-stripped fetal calf serum, L -glutamine (2.0 m M ), Pen-Strep solution (penicillin 100 U/ml, and streptomycin 100 mg/ml). Cells were passaged every 2 days. Cells were grown to approximately 70% confluence in 6-well plates before stimulation.
Hippocampal neurons were obtained from E18 mouse embryos after isolating the hippocampus in Ca 2+ -and Mg 2+ -free HBSS 1 ! . Mice were treated following the guidelines of the Council of Europe Convention ETS123, recently revised as indicated in the Directive 86/609/EEC. In addition, all protocols were approved by the Institutional Animal Care and Use Committee of CSIC-Cajal Institute (Madrid, Spain). Once 8-10 embryonic hippocampi were obtained, they were finely cut, washed twice in HBSS 1 ! buffer, and incubated in 0.1 mg/ml trypsin solution and 1 mg/ml DNAse (Roche Diagnostics GmbH, Mannheim, Germany) for 15 min at 37 ° C. Trypsin and DNAse were then eliminated by washing 3 times, with HBSS 1 ! , and the cut tissue was then triturated using a siliconized pipette. Cells were counted and plated in polylysine-coated (1 mg/ml) 6-well plates containing phenol red-free neurobasal medium supplemented with 2% (v/v) B27 serum-free supplement, 0.25% (v/v) GlutaMAX-I, and 1% (v/v) penicillin/ streptomycin solution. Neurons were maintained under these conditions for 3 days at 5% CO 2 and 37 ° C.
Cells were simultaneously treated with vehicle (ethanol/PBS 1: 10, v/v) and/or E 2 (0.1-1,000 n M ), PPT (0.1-100 n M ), DPN (0.1-100 n M ), T (0.1-1,000 n M ), DHT (0.1-1,000 n M ), IGF-1 (100 ng/ ml), and H 2 O 2 (50 M ). When indicated, the anti-estrogen ICI (1 M ), the PAT inhibitor 2-Br (10 M ), the AKT inhibitor (1 M ), the p38 inhibitor SB (5 M ), the ER ␤ inhibitor THC (1 M ), the IGF-1R inhibitor PPP (100 n M ), and the transcription inhibitor Act (1 g/ml) were added 30 min before E 2 or IGF-1 administration. The translational inhibitor Cxm (10 g/ml), was added 1 h before E 2 administration.
Cell Viability SK-N-BE cell lines were grown to 70% confluence in 6-well plates and stimulated either with vehicle or E 2 (1 n M ) or THC (1 M ). After 24 h of stimulation, cells were treated either with vehicle or with H 2 O 2 50 M for 24 h. After treatment, cells were harvested with trypsin, and counted with Beckman Coulter Model ZM electronic particle (Palo Alto, Calif., USA).
Transfection of Short Interfering RNA SK-N-BE cells, reaching 40-60% confluence, were transfected in a serum-free condition with either Stealth RNAi TM Ngb-silencing RNA or ER ␤ -silencing RNA (siRNA; Invitrogen) according to the manufacturer's instructions, using oligofectamine (Invitrogen) as the transfection reagent. The sequence used for Ngb oligonucleotides was 5 -CGUGAUUGAUGCUGCAGUGACC-AAU-3 ; the sequence used for ER ␤ oligonucleotides was 5 -GAAGAACUCUUUGCCCGGAAAUUUA-3 . The mismatch sequences used as a control were 5 -UGUGAUUUAUGGUGC-AGUAACCAAC-3 and 5 -GAAUCAUUCCGUGC CA AG UA G-A UUA-3 for Ngb and ER ␤ si-RNA, respectively. Briefly, oligofectamine and oligonucleotides (400 and 200 p M for Ngb siRNA and ER ␤ siRNA, respectively) were mixed with Optimem. The mixture was incubated for 20 min at room temperature, diluted with Optimem, and added to the cell medium for 4 h at 37 ° C. The medium was added to cells to reach the growing conditions (i.e., 10% (v/v) serum).
To evaluate the effective silencing of Ngb and ER ␤ , total proteins from cells transfected with MOCK (control), with scramble (mismatch sequence, data not shown), and with Ngb or ER ␤ oligonucleotides were extracted 48 h after transfection, and Ngb and ER ␤ expression was tested by Western blot analysis using antiNgb and anti-ER ␤ antibodies.
Western Blot Assays
After stimulation, the SK-N-BE cell line and hippocampal neurons were lysed and solubilized in 0.125 M Tris, pH 6.8, containing 10% (w/v) SDS and the protease inhibitor cocktail, then the cell lysates were boiled for 2 min. Total proteins were quantified using the Bradford protein assay. Solubilized proteins (20 g) were resolved by 7 or 15% SDS-PAGE at 100 V for 1 h at 25 ° C and then electrophoretically transferred to nitrocellulose for 45 min at 100 V and 4 ° C. The nitrocellulose was treated with 3% (w/v) BSA in 138 m M NaCl, 25 m M Tris, pH 8.0, at 25 ° C for 1 h and then probed overnight at 4 ° C either with anti-Ngb (final dilution 1: 1,000) or anti-ER ␣ MC-20 (final dilution 1: 500) or anti-ER ␤ H-150 (final dilution 1: 3,000) or anti-caspase-3 (final dilution 1: 1,000) or anti-PARP (final dilution 1: 500) or anti-phospho-ERK1/2 (final dilution 1: 200) or anti-phospho-AKT (final dilution 1: 1,000) or anti-phospho-p38 (final dilution 1: 1,000). The nitrocellulose was stripped by Restore Western Blot Stripping Buffer (Pierce Chemical, Rockford, Ill., USA) for 10 min at room temperature and then probed with anti-␤ -tubulin (final dilution 1: 1,000) to normalize total lysate. Moreover, the nitrocellulose incubated with either anti-phospho-ERK1/2 or anti-phospho-AKT or anti-phospho-p38 was stripped and probed with anti-ERK1/2 (final dilution 1: 200), anti-AKT (final dilution 1: 100) and antip38 (final dilution 1: 1,000), respectively. To evidence ER ␣ and ER ␤ levels, electrophoresis was performed in the presence of 5 ng of recombinant ER ␣ and ER ␤ . Antibody reaction was visualized with chemiluminescence Western blot detection reagent.
Densitometric analyses were performed by ImageJ software for Windows. The densitometry quantification of protein was normalized to tubulin.
Statistical Analysis
A statistical analysis was performed by using ANOVA followed by Tukey-Kramer post-test with the GraphPad InStat3 software system for Windows. In all cases, p ! 0.05 was considered significant. Figure 1 shows that E 2 stimulation induced a time-and dose-dependent increase in Ngb levels in SK-N-BE cells ( fig. 1 A, B) . The E 2 (10 n M ) effect on Ngb levels started 30 min after stimulation being significant 1 h after stimulation and remained constant 24 h after hormone stimulation. The E 2 dose-response curve was bell-shaped with a maximum effect at physiological E 2 concentrations (i.e., 1-10 n M ; 24 h stimulation).
Results

E 2 Specifically Increases Ngb Levels in Neurons
In contrast, the male sex steroid hormone DHT and the common precursor of E 2 and DHT, T, did not modify Ngb levels at any tested concentration (data not shown), suggesting the specificity of the E 2 effect. These data were confirmed in freshly isolated mouse hippocampal neurons ( fig. 1 C, D) . Indeed, in these primary neurons, the E 2 effect was rapid (1 h), persistent (24 h) ( fig. 1 C) , and specific in that neither DHT nor T were able to increase Ngb levels at any tested concentration (data not shown). In addition, even in mouse hippocampal neurons, 10 n M E 2 increased Ngb levels which remained significantly higher than control cells even at higher E 2 concentrations ( fig. 1 D) . In line with the slight differences found in the E 2 concentration to obtain the maximum effect in both cell types, 1 and 10 n M were used in the consecutive experiments to stimulate the SK-N-BE cell line and hippocampal neurons, respectively. ER ␤ was necessary for E 2 -induced increase in Ngb levels. The pretreatment of SK-N-BE cells with the pure E 2 antagonist, ICI, completely prevented the E 2 effect on Ngb levels ( fig. 2 A) , suggesting an ER-mediated mechanism. As SK-N-BE cells contain high ER ␤ and low ER ␣ levels ( fig. 2 B) , cells were stimulated with either the specific ER ␣ agonist PPT or the specific ER ␤ agonist DPN to discriminate the role of each ER isoform in the E 2 -induced Ngb level increase. Only 1 and 10 n M DPN mimicked the E 2 effect on Ngb levels ( fig. 2 C) , whereas PPT was unable to increase Ngb levels, at any concentration investigated ( fig. 2 D) . This result was confirmed by cell pretreatment with the specific ER ␤ inhibitor THC, which completely prevented the E 2 effect ( fig. 2 C) . Furthermore, the decrease of ER ␤ protein level by ER ␤ SiRNA transfection caused an impairment of the E 2 ability to increase Ngb levels ( fig. 2 E) . A further confirmation of the ER ␤ involvement in the effect of E 2 effects derives from the results obtained using the flavonoid Nar ( fig. 2 F) . Indeed, we previously reported that this flavonoid is a partial antagonist of E 2 in the presence of ER ␣ [58] and an E 2 mimetic in the presence of ER ␤ [59] . Figure 2 F shows that, like E 2 , 0.1 M Nar was sufficient to increase Ngb levels. This effect persisted at Nar high concentrations (i.e., 1 and 10 M ). ER ␤ was also necessary for the E 2 -induced Ngb increase in mouse primary neurons ( fig. 3 ) . In these cells, containing a similar amount of ER ␣ and ER ␤ ( fig. 3 A) , ICI prevented the E 2 effect ( fig. 3 B) , DPN mimicked the E 2 effect ( fig. 3 C) , whereas PPT was unable to increase Ngb levels ( fig. 3 D) . Cell pretreatment with the specific ER ␤ inhibitor THC further confirmed these results ( fig. 3 E) .
Mechanism Involved in the E 2 -Induced Increase of Ngb Levels in Neurons
ERs are ligand-activated transcription factors which possess both transcriptional and extranuclear activities [48] . Thus, we evaluated the impact on the E 2 -induced Ngb levels of the transcription inhibitor Act, the translation inhibitor Cxm, and the ER membrane localization inhibitor 2-Br [60] . Although the Ngb promoter sequence analysis (accession No. 12,581 from Transcriptional Regulatory Element Database http://rulai.cshl.edu/cgibin/ TRED/tred.cgi?process=home) indicates that no canonical estrogen-responsive element (ERE) is present, SK-N-BE cell pretreatment for 24 h with Act completely prevented the E 2 effect on Ngb levels ( fig. 4 A) . Similarly, Cxm ( fig. 4 B) and 2-Br ( fig. 4 C) impaired the increase of Ngb levels induced by E 2 , suggesting that both transcriptional and extranuclear mechanisms contribute to E 2 effects. This prompted us to evaluate which signal transduction cascade was activated by E 2 in neurons. After 15 min of stimulation with 1 n M E 2 , an increase of AKT and p38 phosphorylation in SK-N-BE cells was observed ( fig. 5 A, B) . The E 2 -induced activation of these kinases was still present 1 h after E 2 stimulation ( fig. 5 A, B) , but only the E 2 -induced p38 phosphorylation persisted 24 h after hormone stimulation (data not shown). By 30 min after 1 n M E 2 stimulation, the ERK1/2 phosphorylation status decreased ( fig. 5 A, B) , in agreement with previous data obtained in cortical neurons [61] . The cell pretreatment with either AKT or p38 or ERK1/2 inhibitors suggested that neither AKT nor ERK1/2 are involved in the E 2 -induced increase of Ngb levels (data not shown), whereas p38 activation was required for both rapid (i.e., 1 h) and long term (i.e., 24 h) E 2 effects on Ngb levels ( fig. 5 C, D) . Similarly, only p38 inhibitor prevents an E 2 -induced Ngb level increase in hippocampal neurons (data not shown). Notably, the SK-N-BE cell transfection with ER ␤ SiRNA reduced both ER ␤ levels and the E 2 ability to induce p38 phosphorylation ( fig. 5 E) . On the other hand, ER ␤ SiRNA did not impair the E 2 -induced AKT activation (data not shown), suggesting that ER ␣ could be the molecular mediator of AKT activation in these cells. Since it has been reported that several actions of E 2 in the nervous system involve cross-talk between ER ␣ and the IGF-1 receptor [62] , we evaluated the possibility that the ER ␤ -dependent E 2 -induced p38 phosphorylation and the Ngb-increased levels are dependent on the ER ␤ -IGF-1 receptor cross-talk. IGF-1 is more efficient than E 2 to activate AKT phosphorylation and cell pretreatment with PPP, the IGF-1 receptor inhibitor, strongly prevented both IGF-1 and E 2 effects on AKT activation ( fig. 5 F) , confirming that cross-talk between the IGF-1 receptor and ERs is important for AKT activation. However, IGF-1 was unable to increase p38 phosphorylation and PPP did not prevent E 2 -induced p38 activation ( fig. 5 F) . In addition, IGF-1 did not modify Ngb levels in SK-N-BE cells ( fig. 5 G) further sustaining the high specificity of the E 2 effect. fig. 6 B) as well as the increase of the 17-kDa active caspase-3 subunit and the cleavage of the caspase-3 substrate PARP ( fig. 6 C) . Staurosporin (2 M for 24 h) was used as positive control of caspase activation ( fig. 6 C) . Notably, the E 2 -protective effect against H 2 O 2 -induced neuron toxicity seems to require ER ␤ , since the cell pretreatment with the specific ER ␤ inhibitor THC completely prevented E 2 effects ( fig. 6 B, C) . In line with this result, E 2 was unable to counteract the H 2 O 2 -induced decrease in cell number ( fig. 6 D) and the activation of the pro-apoptotic cascade (i.e., caspase-3 activation and PARP cleavage) ( fig. 6 E) in Ngb-silenced SK-N-BE cells.
Discussion
The aim of this paper was to identify a possible endogenous modulator of Ngb. Thus, we investigated the effect of E 2 , a well-known neurotrophic and neuroprotective hormone [52] [53] [54] [55] [56] [57] [63] [64] [65] [66] , on Ngb expression. Our results indicated that E 2 increases Ngb levels of about 300% in both the human neuroblastoma cell line and mouse primary hippocampal neurons. Although it has been obtained with a qualitative technique (i.e., Western blot), this effect is conspicuous in that the well-known E 2 effect on cyclin D1 expression, playing a relevant role in E 2 -induced cell proliferation, is only of about 50-70% [67] . In addition, the E 2 -induced Ngb increase is rapid (1 h), persistent (24 h), and specific, being not mimicked by either the male sex steroid hormone DHT or by the common precursor T or by IGF-1, another well-known neuroprotective hormone. These results represent the first evidence for steroid hormone modulation of globin levels in cells. Recently, it has been reported that hemoglobin is specifically expressed in neurons, its expression being upregulated by erythropoietin and accompanied by enhanced brain oxygenation under physiologic and hypoxic conditions [68] . At the present, the relationship between hemoglobin and Ngb in neurons is still unclear. Although hemoglobin ␣ -chains and Ngb are expressed in the same nerve cells, Ngb levels are not increased by erythropoietin [68] . It is therefore unlikely that they have a tightly linked function, e.g. in facilitated oxygen transport; however, hemoglobin and Ngb could fulfill independent tasks in neurons.
It is now well known that sex steroid hormones have numerous effects on the brain throughout the lifespan, beginning during gestation and continuing on into senescence [69] . However, the inability of Ngb to react with androgens renders Ngb a new E 2 target that should be added to the variety of E 2 -specific actions on the brain which include mood, locomotor activity, pain sensitivity, vulnerability to epilepsy, attentional mechanisms, and cognition [64] .
The E 2 effect on Ngb levels is rapid and dose-dependent with the maximum effect at E 2 physiological concentration (i.e., 1-10 n M ). Notably, the E 2 dose-response curve results in being bell-shaped. This is typical for E 2 [70] , whose effects are mediated by two receptor isoforms. Accordingly, the plant-derived flavonoid Nar, which partially blocks the rapid activities of ER ␣ [58] , increased Ngb levels with a plateau at 1 M concentration. This result suggests a functional antagonism between the activities of ER ␣ and ER ␤ in neurons, as has been reported in other cell types [71] .
Although human neuroblastoma cell line and mouse primary hippocampal neurons express different levels of both ER isoforms, the effect of E 2 on Ngb levels specifically requires all ER ␤ activities. In fact, ER ␤ extranuclear and genomic signals cross-talk each other to guarantee both the rapid (1 h) and the persistent (24 h) E 2 effects. In particular, the rapid (15 min) and persistent (24 h) ER ␤ -mediated p38 activation is required for E 2 -induced Ngb increase. The E 2 -dependent activation of p38, a mitogenactivated protein kinase (MAPK) family component, seems to represent a conserved pathway in ER ␤ -based E 2 rapid signals. Indeed, the E 2 -induced ER ␤ -mediated activation of the p38/MAPK occurs in ER ␤ -transfected HeLa cells and in ER ␤ -containing rat myoblasts and colon adenocarcinoma cells [70, 72, 73] . This signaling pathway transduces different E 2 effects depending on the cell context. In fact, p38 activation is required for E 2 -induced apoptosis of cancer cells [72, 73] , for E 2 -induced gene transcription [73] , and for E 2 -induced protection against oxidative stress in neuroblastoma cell line (present results) and in rat myoblasts [Marino, unpubl. results] . Thus, although Ngb promoter does not contain any canonical ERE, it is not surprising that the transcription inhibitor Act completely prevents the increase of the E 2 -induced Ngb levels. The sequence analysis (accession No. 12,581 from Transcriptional Regulatory Element Database http://rulai.cshl.edu/cgi-bin/TRED/tred.cgi? process=home) indicates that several non-canonical half ERE sites are present in the Ngb promoter along with a responsive element for other transcription factors. These results suggest that the E 2 -induced Ngb transcription could be mediated by tethered interactions of ER with other transcription factors to activate gene expression (i.e., indirect genomic mechanism) [48] . Thus, the integration between extranuclear and genomic events may be required to provide plasticity for the neuronal response to E 2 . The hormone rapidly induces AKT activation and ERK dephosphorylation in neuroblastoma cells. These effects are still detected in ER ␣ -containing but ER ␤ -silenced cells. Although these kinases are not directly involved in an E 2 -induced Ngb increase, they could contribute to the E 2 effects in neurons, since AKT activation has been associated with the increase of the antiapoptotic protein Bcl-2 and to the E 2 -induced cell survival [72] , while E 2 protected cortical neurons against oxidative stress by reducing H 2 O 2 -induced activation of ERK1/2 [61] .
The main result reported here is that Ngb is part of the E 2 response to H 2 O 2 -induced toxicity. In fact, exposure to 50 M H 2 O 2 induces neuroblastoma cell death (about 50%) which is accompanied by a dramatic increase in caspase-3 activation. The cell pretreatment with E 2 (1 n M ) decreases cell death and reduces caspase-3 activation triggered by exposure to H 2 O 2 in good accordance with the literature [52-54, 61, 74] . This E 2 effect against H 2 O 2 toxicity is completely prevented by treatment with THC, ER ␤ inhibitor, and by knocking out Ngb using small interfering RNA.
Exposure to H 2 O 2 induces a robust increase of reactive oxygen species in cells (followed by oxidation of lipids, proteins, and DNA), intracellular calcium increase, glutathione depletion, mitochondria dysfunction, and caspase-3 activation followed by apoptotic cell death [74] . It has been demonstrated that E 2 exerts protective effects on several of these cellular events including potent attenuation of lipid peroxidation, attenuated ATP depletion, alleviated intracellular calcium elevation, ablated mitochondrial calcium loading (with the subsequent mitochondrial membrane potential maintenance), reduced caspase-3 activation, and enhanced cell survival ( [74] and present results). At present, it is difficult to discriminate the role played by Ngb in each of these E 2 -induced cellular outcomes because it is not yet clear if they require ER ␣ or ER ␤ or both receptors. Moreover, most of the E 2 -protective effects have been obtained at pharmacological E 2 concentrations (0.1-10 M ) [74] . However, it has recently shown that the elevation of human Ngb expression in neurons prior to insult with H 2 O 2 enhances cell viability and results in a significant decrease in oxidative stress and an increased intracellular ATP concentration [75] . In addition, a linkage of Ngb to oxidative metabolism has been proposed [76] . These data are strongly suggestive of the involvement of Ngb in E 2 -induced attenuated ATP depletion. Furthermore, in the presence of Ngb the initially released cytochrome c may be sequestered by the Ngb [42, 43] and the apoptotic cascade avoided [19] .
In the future, different strategies (e.g., E 2 -induced Ngb localization, association between Ngb and ERs, and E 2 -induced ER-mediated Ngb promoter activity) will substantiate Ngb action in neurons, our laboratories being active in this field. However, from now, Ngb can be regarded as part of signals activated by E 2 to exert neuroprotective effects definitely validating the role played by Ngb as an anti-apoptotic neuroprotective globin.
